Andrea
Pucci

Mid-Level Associate
The future belongs to those who believe in the beauty of their dreams Eleanor Roosevelt

Andrea focuses on corporate law, with particular emphasis on M&A, private equity and venture capital transactions.

He has developed significant experience in the life sciences, healthcare, technology and regulated industries, advising investment funds, industrial players and start-ups on extraordinary transactions, acquisitions, disposals and investments.

Andrea joined LCA in January 2026, where he works within the Corporate M&A Department, assisting Italian and international clients in the negotiation and completion of acquisition and investment transactions, as well as in the management of legal due diligence activities, with particular focus on the life sciences and technology sectors.

He previously gained professional experience at leading international law firms and in Brussels at Medicines for Europe and the European Generic and Biosimilar Association (EGA), where he provided legal and regulatory advice at European level.

Commercial and corporate M&A – Private Equity Start Up & Venture Capital

You might also be interested in

21.09.2026
04.09.2026
LCA advises Impresoft on the sale of 4ward to Lodestar

The deal allows Impresoft to focus on proprietary software, digital transformation and AI, while highlighting 4ward’s industrial f ...

05.08.2026
LCA advises Dokicasa’s shareholders on the sale of the remaining 49% stake t ...

The transaction completes the acquisition process launched in 2024

04.08.2026
LCA on the entry into the share capital of WeRoad by an investment vehicle for whi ...

A secondary investment to support WeRoad’s international growth

03.08.2026
LCA in the acquisition of Hydea by Protos (HIG Capital)

The Firm advised the sellers and management in the group’s external growth transaction

03.08.2026
LCA Studio Legale in the acquisition of Istituto Biochimico Italiano G. Lorenzini ...

A strategic operation in ACS Dobfar Group’s vertical integration path